Sergey Terushkin, MD, FACS Tirzepatide is typically injected once per week Treatment begins with a low starting dose Dose increases are gradual and individualized Some patients remain on a lower maintenance dose Tirzepatide is an injectable medication used in certain patients for blood sugar control and weight management
Imagine stepping into a pod of crisp, crystal-clear, oxygen-infused water designed to rejuvenate your body and mind
Maybe your work schedule changed
Worth every bit of the adjustment period
Human trials show major body-weight reductions, with some evidence suggesting results may approach the 30% range
Personal or family history of medullary thyroid carcinoma or MEN 2 is a contraindication GI side effects: Nausea, diarrhea, vomiting, and constipation are common during escalation